Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway

Telmisartan, a type of angiotensin II (Ang II) receptor inhibitor, is a common agent used to treat hypertension in the clinic. Hypertension increases cardiac afterload and promotes cardiac hypertrophy. However, the ventricular Ang II receptor may be activated in the absence of hypertension. Therefor...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiurong, Lan, Yuhuai, Wang, Yan, Nie, Minghao, Lu, Yanhong, Zhao, Eryang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428554/
https://www.ncbi.nlm.nih.gov/pubmed/28447738
http://dx.doi.org/10.3892/mmr.2017.6318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428554/
https://www.ncbi.nlm.nih.gov/pubmed/28447738
http://dx.doi.org/10.3892/mmr.2017.6318

Ejemplares similares